Contact this trialFirst, we need to learn more about you.
Growth Factor
Pegozafermin for Liver Cirrhosis
Recruiting1 awardPhase 3
Lady Lake, Florida
"This trial will test how well pegozafermin works and how safe it is for people with compensated cirrhosis caused by MASH, which is a severe form of liver disease."
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service